American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

  • ASH is Working with State Level Coalitions to Pass Oral Chemotherapy Parity Legislation

    Over 40 states have already passed cancer drug coverage parity legislation and ASH is now working with three additional state level coalitions to ensure that patients in these states also have equitable coverage for oral and IV anti-cancer treatments.

  • Urge Your Members of Congress to Support Medical Research Funding

    After partisan disputes about “policy riders,” ranging from the defunding of Planned Parenthood to changes to the President’s refugee resettlement program due to the current situation with ISIS/L and Syria, Congress finally reached an agreement in mid-December to fund federal programs and agencies, including the National Institutes of Health (NIH), through the remainder of fiscal year (FY) 2016

View all action alerts
  • ASH 2015 Highlights New Payment Models and Performance Measurement

    The 2015 ASH Quality Symposium and the 2015 ASH Practice Partnership lunch addressed two sides of the issue of how hematologists can demonstrate their value and get paid for providing it.

  • ASH Report from the AMA House of Delegates

    The ASH Delegation has returned from the interim meeting of the American Medical Meeting House of Delegates. Working with the AMA has enabled ASH to influence many policies and special access to influential advisory groups.

  • What Hematologist Need to Know about the Medicare Merit-based Incentive Payment System

    In April, 2015, the Medicare Access and CHIP Reauthorization (MACRA) was signed into law. The headline at the time of passage was the end of the Sustainable Growth Rate (SGR) formula that had for so many years mandated large annual Medicare payment cuts to physicians. MACRA did not just affect the overall payment mechanism – it also created a new pay for performance system for physicians. Many of these elements are similar or identical to the existing pay-for-performance program in Medicare but we will highlight some of the differences.

  • 2015 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

    A list of major initiatives undertaken by ASH in 2015 with the hopes of increasing education and awareness about sickle cell trait (SCT).

View all policy news
back to top